HHC
FURX

Hutchin Hill Capital’s FURIEX PHARMACEUTICALS INC COM STK (DE) FURX Stock Holding History

Hutchin Hill Capital’s Portfolio FURX Stock Details FURX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-7,500
Closed -$256K – 670
2013
Q2 		$256K Buy
+7,500
New +$263K 0.03% 355

Other funds holding FURX

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
MCM
Montibus Capital Management Portland, Oregon $926M AUM

Hutchin Hill Capital's FURX Position: Q3 2013 in Review

Hutchin Hill Capital sold out of FURIEX PHARMACEUTICALS INC COM STK (DE) (FURX) in Q3 2013, closing a stake of 7,500 shares — an estimated $256K sold.

Hutchin Hill Capital first reported a position in FURX in Q2 2013 and held it in 1 quarter. The position peaked at $256K in Q2 2013. 85 funds tracked by Wall St. Rank hold FURX as of Q3 2013.

  • Hutchin Hill Capital reported no remaining FURIEX PHARMACEUTICALS INC COM STK (DE) position as of Q3 2013 after selling out during the quarter.
  • Hutchin Hill Capital sold 7,500 FURIEX PHARMACEUTICALS INC COM STK (DE) shares in Q3 2013, an estimated $256K.
  • Hutchin Hill Capital first reported a position in FURIEX PHARMACEUTICALS INC COM STK (DE) in Q2 2013 and held it in 1 quarter.
  • Hutchin Hill Capital's FURIEX PHARMACEUTICALS INC COM STK (DE) position peaked at $256K in Q2 2013.
  • 85 funds tracked by Wall St. Rank held FURIEX PHARMACEUTICALS INC COM STK (DE) as of Q3 2013.

Based on Hutchin Hill Capital's 13F filing for Q3 2013, filed 14 Nov 2013.